Closing Bell: Briacell Therapeutics Corp up on Tuesday (BCT)

Briacell Therapeutics Corp opened trading today at $0.94 and closed at $0.97. It traded at a low of $0.89 to a high of $0.97.

Shares advanced 4.30% from the previous day's close of $0.93.

During the day across North America, the TSX Composite closed -0.26% at 22813.75, the S&P 500 closed 1.08% at 5564.41, the Dow Jones Industrial Average closed 0.32% at 40415.44 and the Nasdaq Composite closed 1.58% at 18007.57.

Briacell Therapeutics Corp traded under BCT on the Toronto Stock Exchange (TSX).

A total of 7,240 shares was traded during the last trading day, with total trades of 19, with an average volume of 62,050 over 5 days.

The TSX market on the whole today saw 3,093 price advancers against 2,137 declines and 96 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.86 (July 22,2024). Moreover, the shares have plummeted -88.49% in the last 12 months, while in 2024, they have plummeted -87.56%.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $17.00 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a None company headquartered in Vancouver, CAN.

Currently, Briacell Therapeutics Corp's consensus rating is "Strong Buy" based on 1 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..